COGZF
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | 0.03 | $26M | $3M |
| 2025 Q4 | 0.04 | $30M | $7M |
| 2024 Q2 | 0.02 | $24M | $5M |
| 2024 Q4 | 0.02 | $23M | $6M |
| 2023 Q2 | 0.01 | $19M | -$786,349 |
| 2023 Q4 | 0.02 | $23M | $367,206 |
| 2022 Q2 | 0.00 | $20M | -$1M |
| 2022 Q4 | 0.02 | $23M | $5M |